Read + Share
Hayashi T, Shibata M, Oe S, Miyagawa K, et al. C-reactive protein can predict dose intensity, time to treatment failure and
overall survival in HCC treated with lenvatinib. PLoS One 2020;15:e0244370.
PMID: 33351844
|
 |
|
Hayashi T, Shibata M, Oe S, Miyagawa K, et al. C-reactive protein can predict dose intensity, time to treatment failure and
overall survival in HCC treated with lenvatinib. PLoS One 2020;15:e0244370.
PMID: 33351844
|
|
|
|